SynBiotic SE (XTER:SBX) EBIT per Share : €-5.73 (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is SynBiotic SE EBIT per Share?

SynBiotic SE's EBIT per Share for the six months ended in Dec. 2023 was €0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €-5.73.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for SynBiotic SE's EBIT per Share or its related term are showing as below:

XTER:SBX's 3-Year EBIT Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 8
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

SynBiotic SE's EBIT for the six months ended in Dec. 2023 was €0.00 Mil.

SynBiotic SE EBIT per Share Historical Data

The historical data trend for SynBiotic SE's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynBiotic SE EBIT per Share Chart

SynBiotic SE Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.05

-0.53

-4.28

-6.37

-2.46

SynBiotic SE Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Dec23
EBIT per Share	Get a 7-Day Free Trial				-0.13	-3.46	-0.35	-5.39	-

SynBiotic SE EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

SynBiotic SE's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-11.676	/	4.749
=	-2.46

SynBiotic SE's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	0	/	4.749
=	0.00

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-5.73

SynBiotic SE (XTER:SBX) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

SynBiotic SE EBIT per Share Related Terms

Thank you for viewing the detailed overview of SynBiotic SE's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

SynBiotic SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SynBiotic SE (XTER:SBX) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Barer Strasse 7, Munich, BY, DEU, 80333

Website

https://www.synbiotic.com

SynBiotic SE is engaged in the development of Phyto-cannabinoids and other herbal compounds concentrated molecules as well as the development of wellness products. The company engages in synthetic production, drug development, cannabinoids, dietary supplements and cosmetic products. Geographical presence in Germany, Austria, UK, Switzerland and Other countries. Majority of its revenue comes from domestic market.

Executives

Daniel Kruse

Geschäftsführender Direktor

SynBiotic SE Headlines

No Headlines